(Q46958770)

26 December 2017

title

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya (English)

1 reference

26 December 2017

0 references

1 reference

1 reference

Hanke T

1

1 reference

26 December 2017

McMichael AJ

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

26 December 2017

published in

Nature Medicine

1 reference

26 December 2017

volume

6

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

951-955

1 reference

26 December 2017

Is an HIV vaccine possible?

cites work

1 reference

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

7 January 2021

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

7 January 2021

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

1 reference

7 January 2021

Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes

1 reference

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

7 January 2021

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

1 reference

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

7 January 2021

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

7 January 2021

T cell responses and viral escape

1 reference

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

7 January 2021

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

7 January 2021

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

1 reference

7 January 2021

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

1 reference

7 January 2021

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

1 reference

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

7 January 2021

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya

1 reference

7 January 2021

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

1 reference

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

7 January 2021

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

1 reference

7 January 2021

Expression in COS cells of a mouse-human chimaeric B72.3 antibody

1 reference

7 January 2021

Repressor titration: a novel system for selection and stable maintenance of recombinant plasmids

1 reference

7 January 2021

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

1 reference

7 January 2021

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

1 reference

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

7 January 2021

Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells

1 reference

7 January 2021

Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509)

1 reference

7 January 2021

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

1 reference

7 January 2021

Identifiers

DOI

10.1038/79626

1 reference

26 December 2017

1 reference

26 December 2017